Skip to main content
SpringerLink
Log in

Einfluss der Anti-TNF-α-Antikörper-Therapie auf Hospitalisation, Operationshäufigkeit und Mortalität bei CED-Patienten

Impact of anti-TNF-α antibody therapy on hospitalization, frequency of operations and mortality in IBD patients

  • Journal Club
  • Published:
coloproctology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Yu H, MacIsaac D, Wong JJ, Sellers ZM, Wren AA, Bensen R, Kin C, Par KT (2018) Market share and costs of biologic therapies for inflammatory bowel disease in the USA. Aliment Pharmacol Ther 47:364–370

    Article  CAS  Google Scholar 

  2. Kirchgesner J, Lemaitre M, Rudnichi A, Racine A, Zureik M, Carbonnel F, Dray-Spira R (2014) Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009. Aliment Pharmacol Ther 45:37–49

    Article  Google Scholar 

  3. Annese V, Duricova D, Gower-Rousseau C, Jess T, Langholz E (2016) Impact of new treatments on hospitalisation, surgery, infection, and mortality in IBD: a focus paper by the Epidemiology Committee of ECCO. J Crohns Colitis 10(2):216–225. https://doi.org/10.1093/ecco-jcc/jjv190

    Article  PubMed  Google Scholar 

  4. Abelson JS, Michelassi F, Mao J, Sedrakyan A, Yeo H (2018) Higher surgical morbidity for ulcerative colitis patients in the era of biologics. Ann Surg 268:311–317

    Article  Google Scholar 

  5. Kucharzik T, Dignass AU, Atreya R et al (2018) Aktualisierte S3-Leitlinie Colitis ulcerosa der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Z Gastroenterol 56:1087–1169

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Allgemein- und Visceralchirurgie, St. Elisabethen-Klinikum, Oberschwabenklinik, Elisabethen-Str. 15, 88212, Ravensburg, Deutschland

    E. Jehle

Authors
  1. E. Jehle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Jehle.

Ethics declarations

Interessenkonflikt

E. Jehle gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jehle, E. Einfluss der Anti-TNF-α-Antikörper-Therapie auf Hospitalisation, Operationshäufigkeit und Mortalität bei CED-Patienten. coloproctology 41, 46–48 (2019). https://doi.org/10.1007/s00053-018-0325-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00053-018-0325-x

Search

Navigation